Detalhe da pesquisa
1.
Bevacizumab plus FOLFIRI after failure of platinum-etoposide first-line chemotherapy in patients with advanced neuroendocrine carcinoma (PRODIGE 41-BEVANEC): a randomised, multicentre, non-comparative, open-label, phase 2 trial.
Lancet Oncol
; 24(3): 297-306, 2023 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-36739879
2.
Genetic counselling referral practices for patients with pancreatic adenocarcinoma: A French retrospective multicentre observational cohort study (CAPANCOGEN).
Pancreatology
; 23(6): 622-629, 2023 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-37394294
3.
Cannabidiol-drug interaction in cancer patients: A retrospective study in a real-life setting.
Br J Clin Pharmacol
; 89(7): 2322-2328, 2023 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-36849134
4.
Prevalence of cannabidiol (CBD) consumption and cancer patients' expectations in one oncology day-hospital: A cross-sectional study and questionnaire validation.
J Oncol Pharm Pract
; : 10781552231187136, 2023 Jul 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-37437182
5.
FOLFIRI plus BEvacizumab or aFLIbercept after FOLFOX-bevacizumab failure for COlorectal cancer (BEFLICO): An AGEO multicenter study.
Int J Cancer
; 151(11): 1978-1988, 2022 Dec 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-35833561
6.
Dynapenia in digestive cancer outpatients: association with markers of functional and nutritional status (the FIGHTDIGO study).
Support Care Cancer
; 30(1): 207-215, 2022 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-34251540
7.
Total gastrectomy for severe proton pump inhibitor-induced hypomagnesemia in a MEN1/Zollinger Ellison syndrome patient.
Pancreatology
; 21(1): 236-239, 2021 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-33309626
8.
Frequency of capsid substitutions associated with GS-6207 in vitro resistance in HIV-1 from antiretroviral-naive and -experienced patients.
J Antimicrob Chemother
; 75(6): 1588-1590, 2020 06 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-32154864
9.
HIV-1 protease, Gag and gp41 baseline substitutions associated with virological response to a PI-based regimen.
J Antimicrob Chemother
; 74(6): 1679-1692, 2019 06 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-30768160
10.
New mechanisms of resistance in virological failure to protease inhibitors: selection of non-described protease, Gag and Gp41 mutations.
J Antimicrob Chemother
; 74(7): 2019-2023, 2019 07 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-31050739
11.
Presence of Human Papillomavirus (HPV) Apolipoprotein B Messenger RNA Editing, Catalytic Polypeptide-Like 3 (APOBEC)-Related Minority Variants in HPV-16 Genomes From Anal and Cervical Samples but Not in HPV-52 and HPV-58.
J Infect Dis
; 218(7): 1027-1036, 2018 08 24.
Artigo
em Inglês
| MEDLINE | ID: mdl-29788374
12.
Characterization update of HIV-1 M subtypes diversity and proposal for subtypes A and D sub-subtypes reclassification.
Retrovirology
; 15(1): 80, 2018 12 22.
Artigo
em Inglês
| MEDLINE | ID: mdl-30577842
13.
Feasibility of systematic handgrip strength testing in digestive cancer patients treated with chemotherapy: The FIGHTDIGO study.
Cancer
; 124(7): 1501-1506, 2018 04 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-29278424
14.
No impact of HIV-1 protease minority resistant variants on the virological response to a first-line PI-based regimen containing darunavir or atazanavir.
J Antimicrob Chemother
; 73(1): 173-176, 2018 Jan 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-29077926
15.
High virological suppression regardless of the genotypic susceptibility score after switching to a dolutegravir-based regimen: week 48 results in an observational cohort.
J Antimicrob Chemother
; 73(6): 1665-1671, 2018 06 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-29528412
16.
Dynapenia could predict chemotherapy-induced dose-limiting neurotoxicity in digestive cancer patients.
BMC Cancer
; 18(1): 955, 2018 Oct 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-30286724
17.
HIV-1 DNA ultra-deep sequencing analysis at initiation of the dual therapy dolutegravir + lamivudine in the maintenance DOLULAM pilot study.
J Antimicrob Chemother
; 72(10): 2831-2836, 2017 10 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-29091218
18.
Switch as maintenance to elvitegravir/cobicistat/emtricitabine/tenofovir disoproxil fumarate: week 48 results in a clinical cohort.
J Antimicrob Chemother
; 72(6): 1745-1751, 2017 06 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-28186251
19.
Enhanced cooperative interactions at the nanoscale in spin-crossover materials with a first-order phase transition.
Phys Rev Lett
; 110(23): 235701, 2013 Jun 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-25167512
20.
Investigation on NMR relaxivity of nano-sized cyano-bridged coordination polymers.
Inorg Chem
; 52(23): 13402-14, 2013 Dec 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-24245933